BIOCRYST PHARM (BO1 BE) stock market data APIs
€5.6632
0(0%)
as of October 17, 2025
Try our APIs with
free plan!
BIOCRYST PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BO1.BE.
Prev. Close
5.6632
Open
5.6632
High
5.6632
Low
5.6632
52 wk Range
5.536-9.896
Market Cap
1 856 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIOCRYST PHARM data using free add-ons & libraries
Get BIOCRYST PHARM Fundamental Data
BIOCRYST PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIOCRYST PHARM News
New
BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock?
BioCryst Pharmaceuticals (BCRX) shares ended the last trading session 6.1% higher at $6.81. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the sess...
Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX
Shares of Astria Therapeutics ATXS rallied 37.1% on Tuesday after the company signed a definitive agreement to be acquired by BioCryst Pharmaceuticals BCRX for a mix of cash and stock, representing a...
How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals
BioCryst Pharmaceuticals has seen its Fair Value Estimate rise from $16.73 to $18.50, signaling a more optimistic view of the company’s intrinsic worth. At the same time, the Discount Rate has inche...
Top Midday Decliners
Orion (OEC) shares sank 16% amid heavy trading a day after the company lowered its fiscal 2025 guida PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
